-
Symbol
-
GLUE on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
5,663,265 shares
-
Security Ownership %
-
8.7%
Adam Goulburn ownership in Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share (GLUE)
21 Jan 2026 - Adam Goulburn has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,663,265 shares of Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share (GLUE).
This represents 8.7% ownership of the company.
In their previous filing dated 03 Oct 2025, Dimension Capital I, L.P. had reported owning 4,757,563 shares, indicating an increase of +19%.
.